These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21447610)

  • 21. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice.
    Ghanayem BI; Hoffler U
    Curr Drug Metab; 2007 Oct; 8(7):728-49. PubMed ID: 17979661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of genetically modified mouse models for evaluation of carcinogenic risk: considerations for the laboratory animal scientist.
    Recio L; Everitt J
    Comp Med; 2001 Oct; 51(5):399-405. PubMed ID: 11924798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Of mice and models: improved animal models for biomedical research.
    Bockamp E; Maringer M; Spangenberg C; Fees S; Fraser S; Eshkind L; Oesch F; Zabel B
    Physiol Genomics; 2002 Dec; 11(3):115-32. PubMed ID: 12464688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of metamitron by human p450 expressed in transgenic tobacco cell cultures.
    Bode M; Haas M; Faymonville T; Thiede B; Schuphan I; Schmidt B
    J Environ Sci Health B; 2006; 41(3):201-22. PubMed ID: 16484082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
    Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
    Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of toxicology testing: the role of pigs.
    Helke KL; Swindle MM
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):127-39. PubMed ID: 23216131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment.
    Cheung C; Gonzalez FJ
    J Pharmacol Exp Ther; 2008 Nov; 327(2):288-99. PubMed ID: 18682571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic models in xenobiotic metabolism and toxicology.
    Gonzalez FJ
    Toxicology; 2002 Dec; 181-182():237-9. PubMed ID: 12505317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes.
    Pineau T; Costet P; Puel O; Pfohl-Leszkowicz A; Lesca P; Alvinerie M; Galtier P
    Toxicol Lett; 1998 Dec; 102-103():459-64. PubMed ID: 10022296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.
    Hewitt NJ; Edwards RJ; Fritsche E; Goebel C; Aeby P; Scheel J; Reisinger K; Ouédraogo G; Duche D; Eilstein J; Latil A; Kenny J; Moore C; Kuehnl J; Barroso J; Fautz R; Pfuhler S
    Toxicol Sci; 2013 Jun; 133(2):209-17. PubMed ID: 23539547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using cytochrome P-450 gene knock-out mice to study chemical metabolism, toxicity, and carcinogenicity.
    Ghanayem BI; Wang H; Sumner S
    Toxicol Pathol; 2000; 28(6):839-50. PubMed ID: 11127301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
    Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
    Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of gene knockout and transgenic mice in the study of xenobiotic metabolism.
    Gonzalez FJ
    Drug Metab Rev; 2003 Nov; 35(4):319-35. PubMed ID: 14705864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 knockout mice: new toxicological models.
    McKinnon RA; Nebert DW
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):783-7. PubMed ID: 9784916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic animal mutation models: a review of the models and how they function.
    Dean S
    Methods Mol Biol; 2012; 817():377-97. PubMed ID: 22147581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The study of xenobiotic-metabolizing enzymes and their role in toxicity in vivo using targeted gene disruption.
    Gonzalez FJ
    Toxicol Lett; 1998 Dec; 102-103():161-6. PubMed ID: 10022249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic animals in toxicology.
    Ladiges WC; Ware CB
    Curr Protoc Toxicol; 2001; Chapter 1():Unit1.3. PubMed ID: 23045021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.
    Choudhuri S; Patton GW; Chanderbhan RF; Mattia A; Klaassen CD
    Toxicol Sci; 2018 Jan; 161(1):5-22. PubMed ID: 28973688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and characterization of a novel "family-shuffling" technology adapted to membrane enzyme: application to P450s involved in xenobiotic metabolism.
    Abécassis V; Pompon D; Truan G
    Adv Exp Med Biol; 2001; 500():319-22. PubMed ID: 11764959
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictive models for nanotoxicology: current challenges and future opportunities.
    Clark KA; White RH; Silbergeld EK
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):361-3. PubMed ID: 21310205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.